BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25596362)

  • 1. Novel biomarkers and advanced imaging modalities in the early detection of prostate cancer.
    Parsons JK
    J Urol; 2015 Apr; 193(4):1084-5. PubMed ID: 25596362
    [No Abstract]   [Full Text] [Related]  

  • 2. The quest for the perfect prostate biopsy continues.
    Gomella LG
    J Urol; 2012 Jun; 187(6):1954-5. PubMed ID: 22503025
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of the Prostate-An Update.
    Das CJ; Razik A; Sharma S
    Semin Roentgenol; 2018 Jul; 53(3):219-226. PubMed ID: 30031415
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies.
    Brock M; Löppenberg B; Roghmann F; Pelzer A; Dickmann M; Becker W; Martin-Seidel P; Sommerer F; Schenk L; Palisaar RJ; Noldus J; von Bodman C
    J Urol; 2015 Apr; 193(4):1191-7. PubMed ID: 25451832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transrectal prostate biopsy.
    Ismail MT; Gomella LG
    Urol Clin North Am; 2013 Nov; 40(4):457-72. PubMed ID: 24182969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of transrectal ultrasonography in prostate cancer.
    Ghai S; Toi A
    Radiol Clin North Am; 2012 Nov; 50(6):1061-73. PubMed ID: 23122038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and magnetic resonance image response in targeted focal cryotherapy to ablate targeted biopsy-proven index lesion of prostate cancer.
    Inoue Y; Ushijima S; Shiraishi T; Fujihara A; Hongo F; Ukimura O
    Int J Urol; 2019 Feb; 26(2):317-319. PubMed ID: 30485553
    [No Abstract]   [Full Text] [Related]  

  • 9. MR Imaging-Guided Focal Treatment of Prostate Cancer: An Update.
    Nour SG
    Radiol Clin North Am; 2018 Mar; 56(2):301-318. PubMed ID: 29420984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification.
    Mendhiratta N; Rosenkrantz AB; Meng X; Wysock JS; Fenstermaker M; Huang R; Deng FM; Melamed J; Zhou M; Huang WC; Lepor H; Taneja SS
    J Urol; 2015 Dec; 194(6):1601-6. PubMed ID: 26100327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
    Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
    NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
    Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment.
    Schilling D; Stenzl A
    J Urol; 2010 Feb; 183(2):527-8; discussion 528. PubMed ID: 20006885
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer.
    Veltri RW
    BJU Int; 2016 Jan; 117(1):12-3. PubMed ID: 26676682
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
    Hambrock T; Somford DM; Hoeks C; Bouwense SA; Huisman H; Yakar D; van Oort IM; Witjes JA; Fütterer JJ; Barentsz JO
    J Urol; 2010 Feb; 183(2):520-7. PubMed ID: 20006859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
    Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
    Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment.
    Ukimura O
    J Urol; 2014 Dec; 192(6):1648; discussion 1649. PubMed ID: 25194546
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment.
    Phillips J
    J Urol; 2014 Dec; 192(6):1649; discussion 1649. PubMed ID: 25194544
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer.
    Trabulsi EJ; Sackett D; Gomella LG; Halpern EJ
    Urology; 2010 Nov; 76(5):1025-33. PubMed ID: 20719368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of echoguided transrectal biopsy of the prostate gland].
    Herranz Amo F
    Actas Urol Esp; 1998 Jun; 22(6):461-71. PubMed ID: 9734121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.